{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T08:01:32Z","timestamp":1778227292007,"version":"3.51.4"},"reference-count":51,"publisher":"Wiley","issue":"S4","license":[{"start":{"date-parts":[[2022,5,6]],"date-time":"2022-05-06T00:00:00Z","timestamp":1651795200000},"content-version":"vor","delay-in-days":5,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Haemophilia"],"published-print":{"date-parts":[[2022,5]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Introduction<\/jats:title><jats:p>The inherited bleeding disorders (IBD) community has witnessed significant therapeutic advances recently, yet important gaps persist, particularly for those with rare disorders and historically underserved populations.<\/jats:p><\/jats:sec><jats:sec><jats:title>Aims<\/jats:title><jats:p><jats:list list-type=\"explicit-label\">\n<jats:list-item><jats:p>To create a national research blueprint agenda, led by the National Hemophilia Foundation (NHF), enhancing patient\u2010centric principles, accelerate research progress and address important gaps in care.<\/jats:p><\/jats:list-item>\n<jats:list-item><jats:p>To review critical gaps that remain to be addressed in women with IBDs, who face specific bleeding challenges.<\/jats:p><\/jats:list-item><\/jats:list><\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>The NHF research blueprint research agenda was defined by input from across the community, including caregivers and patients who are considered subject matter experts of their IBD, research leaders, allied health professionals and specialists, and representatives of the biopharmaceutical industry. In addition, two medical experts in the field of IBDs performed a comprehensive review to address the knowledge gaps in women with IBDs.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Two foundational principles of the NHF blueprint are: (1) it must deliver on key issues that significantly impact the lives of those affected by IBDs, and (2) the priorities defined are relevant and actionable aimed to achieve health equity among all those affected by IBDs. A multidisciplinary approach is necessary for an optimal management of puberty, transition to adulthood and pregnancy. Even if strict guidelines are followed, recent studies show that women with IBDs are still facing a high burden.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>NHF blueprint will be issued in 2022. A specific research agenda is needed in women with IBDs to further improve their management and quality of life.<\/jats:p><\/jats:sec>","DOI":"10.1111\/hae.14532","type":"journal-article","created":{"date-parts":[[2022,5,6]],"date-time":"2022-05-06T06:07:08Z","timestamp":1651817228000},"page":"53-60","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Big picture initiatives in bleeding disorders"],"prefix":"10.1111","volume":"28","author":[{"given":"Antoine","family":"Rauch","sequence":"first","affiliation":[{"name":"CHU Lille Hematology Transfusion  LILLE France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leonard A.","family":"Valentino","sequence":"additional","affiliation":[{"name":"National Hemophilia Foundation  New York New York USA"},{"name":"Rush University  Chicago Illinois USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin","family":"Mills","sequence":"additional","affiliation":[{"name":"National Hemophilia Foundation  New York New York USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michelle L.","family":"Witkop","sequence":"additional","affiliation":[{"name":"National Hemophilia Foundation  New York New York USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria E.","family":"Santaella","sequence":"additional","affiliation":[{"name":"National Hemophilia Foundation  New York New York USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donna","family":"DiMichele","sequence":"additional","affiliation":[{"name":"National Hemophilia Foundation  New York New York USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Recht","sequence":"additional","affiliation":[{"name":"American Thrombosis and Hemostasis Network  Rochester New York USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sophie","family":"Susen","sequence":"additional","affiliation":[{"name":"CHU Lille Hematology Transfusion  LILLE France"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2022,5,6]]},"reference":[{"key":"e_1_2_10_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2021.100726"},{"key":"e_1_2_10_3_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1601561"},{"key":"e_1_2_10_4_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.17791"},{"key":"e_1_2_10_5_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.13423"},{"key":"e_1_2_10_6_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2516.2008.01930.x"},{"key":"e_1_2_10_7_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2007.02563.x"},{"key":"e_1_2_10_8_1","doi-asserted-by":"publisher","DOI":"10.1160\/TH11-03-0180"},{"key":"e_1_2_10_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.blre.2019.100633"},{"key":"e_1_2_10_10_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijgo.12666"},{"key":"e_1_2_10_11_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamapediatrics.2019.5040"},{"key":"e_1_2_10_12_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.2004.00176.x"},{"key":"e_1_2_10_13_1","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0000000000003411"},{"key":"e_1_2_10_14_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2020003265"},{"key":"e_1_2_10_15_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2019.225656"},{"key":"e_1_2_10_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2012.07.010"},{"key":"e_1_2_10_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpag.2018.06.008"},{"key":"e_1_2_10_18_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.1990.tb16249.x"},{"key":"e_1_2_10_19_1","doi-asserted-by":"publisher","DOI":"10.1111\/hae.14283"},{"key":"e_1_2_10_20_1","doi-asserted-by":"publisher","DOI":"10.1182\/hematology.2020000140"},{"key":"e_1_2_10_21_1","doi-asserted-by":"publisher","DOI":"10.1182\/asheducation-2016.1.236"},{"key":"e_1_2_10_22_1","doi-asserted-by":"publisher","DOI":"10.1111\/hae.14221"},{"key":"e_1_2_10_23_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2516.2008.01824.x"},{"key":"e_1_2_10_24_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2020003264"},{"issue":"4","key":"e_1_2_10_25_1","article-title":"Antifibrinolytics for heavy menstrual bleeding","volume":"4","author":"Bryant\u2010Smith AC","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_10_26_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2009.07610.x"},{"issue":"11","key":"e_1_2_10_27_1","article-title":"Non\u2010surgical interventions for treating heavy menstrual bleeding (menorrhagia) in women with bleeding disorders","volume":"11","author":"Ray S","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_10_28_1","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0b013e3182839e0e"},{"issue":"8","key":"e_1_2_10_29_1","article-title":"20 \u03bcg versus >20\u00a0\u03bcg estrogen combined oral contraceptives for contraception","volume":"2013","author":"Gallo MF","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_10_30_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.2004.00305.x"},{"key":"e_1_2_10_31_1","doi-asserted-by":"publisher","DOI":"10.1111\/hae.12184"},{"key":"e_1_2_10_32_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-05-642223"},{"key":"e_1_2_10_33_1","doi-asserted-by":"publisher","DOI":"10.1111\/hae.14379"},{"key":"e_1_2_10_34_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2019000964"},{"key":"e_1_2_10_35_1","doi-asserted-by":"publisher","DOI":"10.1111\/hae.13061"},{"key":"e_1_2_10_36_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.16133"},{"key":"e_1_2_10_37_1","doi-asserted-by":"publisher","DOI":"10.1111\/1471-0528.14592"},{"key":"e_1_2_10_38_1","unstructured":"MASAC guidelines for perinatal management of women with bleeding disorders and carriers of hemophilia A or B (document 251)."},{"key":"e_1_2_10_39_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2018.209619"},{"key":"e_1_2_10_40_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2017005082"},{"key":"e_1_2_10_41_1","doi-asserted-by":"publisher","DOI":"10.1111\/jth.14825"},{"key":"e_1_2_10_42_1","doi-asserted-by":"publisher","DOI":"10.1111\/jth.15102"},{"key":"e_1_2_10_43_1","doi-asserted-by":"publisher","DOI":"10.1111\/jth.15311"},{"key":"e_1_2_10_44_1","doi-asserted-by":"publisher","DOI":"10.1111\/jth.14696"},{"key":"e_1_2_10_45_1","doi-asserted-by":"publisher","DOI":"10.1111\/hae.14448"},{"key":"e_1_2_10_46_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2018023713"},{"key":"e_1_2_10_47_1","doi-asserted-by":"publisher","DOI":"10.1111\/jth.15397"},{"key":"e_1_2_10_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.blre.2021.100826"},{"key":"e_1_2_10_49_1","doi-asserted-by":"publisher","DOI":"10.1111\/hae.14465"},{"key":"e_1_2_10_50_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-11-122945"},{"key":"e_1_2_10_51_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2020002081"},{"key":"e_1_2_10_52_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2018017418"}],"container-title":["Haemophilia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/hae.14532","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/hae.14532","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/hae.14532","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T09:43:58Z","timestamp":1698831838000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/hae.14532"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":51,"journal-issue":{"issue":"S4","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["10.1111\/hae.14532"],"URL":"https:\/\/doi.org\/10.1111\/hae.14532","archive":["Portico"],"relation":{},"ISSN":["1351-8216","1365-2516"],"issn-type":[{"value":"1351-8216","type":"print"},{"value":"1365-2516","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"2022-01-14","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-02-22","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-05-06","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}